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Abstract: BACKGROUND Three-dimensional (3D) transesophageal echocardiography (TEE) technol-
ogy is now widely used intraoperatively in cardiac surgery. Left ventricular (LV) measurements with
3D transthoracic echocardiography correlate better with cardiac magnetic resonance measurements com-
pared with traditional two-dimensional (2D) transthoracic echocardiography. In this study, we compared
intraoperative 3D TEE against 2D TEE regarding quantitative indices of LV function. METHODS We
performed 2D TEE and 3D TEE examinations on 156 patients scheduled for elective cardiac surgery.
Two-dimensional TEE images of midesophageal 4-, 2-chamber, and long-axis views were acquired. LV
volumes and ejection fraction (EF) were calculated by Simpson’s method. Three-dimensional full-volume
images were recorded to calculate by a semiautomated procedure LV volumes (indexed to body surface
area) and EF. 3D and 2D LV dimensions and function, image quality, time for acquisition/analyses,
and reproducibility were compared by the Wilcoxon matched-pairs signed-ranks test. Pairwise differ-
ences between 3D and 2D data were compared using 95% prediction intervals (PIs) and Bland-Altman
methodology. 3D volumes were also plotted against 2D volumes in scatter plots using a 3-zone error
grid. RESULTS There was no significant difference between 3D and 2D in the estimation of EF (P =
0.227; median pairwise difference, -0.4% [95% PIs, -8.6% to 8.8%]). 3D LV indexed end-diastolic volumes
(iEDVs) and end-systolic volumes (iESVs) were larger than 2D iEDVs (P < 0.001; median pairwise dif-
ference, 3.3 mL/m [95% PIs, -9.4 to 14.1 mL/m] and iESV: P < 0.001; median pairwise difference, 1.4
mL/m [95% PIs, -5.2 to 10.1 mL/m]). In the vast majority of cases (98.8% of cases for iEDV and 92.8%
of cases for iESV), the difference between 2D and 3D TEE indexed volumes did not alter classification
into normal, mildly to moderately dilated, or severely dilated volumes, as demonstrated by the 3-zone
error grid analysis. Acquisition of 3D TEE image and analysis were not feasible in 4 patients (2.5%) for
whom a quantitative 2D assessment of the LV was also impossible. 3D and 2D quality image was similar
(P = 0.206). There was no difference in 3D versus 2D acquisition time (P = 0.805; pairwise difference = 2
seconds [95% PIs, -20 to 35 seconds]), but 3D analysis required more time (P < 0.001; pairwise difference
= 117 seconds [95% PIs, 66 to 197 seconds]). Differences in repeated 3D versus 2D indexed volumes were
not statistically significant, both considering interobserver reproducibility (iEDV: P = 0.125; pairwise
difference, 0.26 ± 1.76 mL [95% PIs, -3.58 to 3.73 mL] and iESV: P = 0.126; pairwise difference, -0.16
± 1.67 mL [95% PIs, -3.96 to 3.69 mL]) and intraobserver reproducibility (iEDV: P = 0.975; pairwise
difference, -0.02 ± 1.20 mL [95% PIs, -2.32 to 2.08 mL] and iESV: P = 0.228; pairwise difference, -0.19
± 1.13 mL [95% PIs, -2.47 to 2.53 mL]). CONCLUSIONS Intraoperative 3D TEE quantification of LV
global function, image acquisition time, and reproducibility was not statistically different when compared
with 2D TEE. It was however associated with calculation of larger LV volumes and a longer analysis time.
Nevertheless, the 3-zone error grid analysis of the LV indexed volumes showed that the difference between
3D and 2D measurements does not affect the LV classification as normal, mildly to moderately dilated,
or severely dilated.
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Intraoperative transesophageal echocardiography (TEE) is now a well-established monitoring technique during cardiac surgery. TEE allows assessment of changes in left 
ventricular (LV) preload and afterload and for evaluation of 
myocardial dysfunction.1–3
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BACKGROUND: Three-dimensional (3D) transesophageal echocardiography (TEE) technology is 
now widely used intraoperatively in cardiac surgery. Left ventricular (LV) measurements with 3D 
transthoracic echocardiography correlate better with cardiac magnetic resonance measurements 
compared with traditional two-dimensional (2D) transthoracic echocardiography. In this study, we 
compared intraoperative 3D TEE against 2D TEE regarding quantitative indices of LV function.
METHODS: We performed 2D TEE and 3D TEE examinations on 156 patients scheduled for elec-
tive cardiac surgery. Two-dimensional TEE images of midesophageal 4-, 2-chamber, and long-axis 
views were acquired. LV volumes and ejection fraction (EF) were calculated by Simpson’s method. 
Three-dimensional full-volume images were recorded to calculate by a semiautomated procedure 
LV volumes (indexed to body surface area) and EF. 3D and 2D LV dimensions and function, image 
quality, time for acquisition/analyses, and reproducibility were compared by the Wilcoxon matched-
pairs signed-ranks test. Pairwise differences between 3D and 2D data were compared using 95% 
prediction intervals (PIs) and Bland–Altman methodology. 3D volumes were also plotted against 
2D volumes in scatter plots using a 3-zone error grid.
RESULTS: There was no significant difference between 3D and 2D in the estimation of EF 
(P  =  0.227; median pairwise difference, −0.4% [95% PIs, −8.6% to 8.8%]). 3D LV indexed 
end-diastolic volumes (iEDVs) and end-systolic volumes (iESVs) were larger than 2D iEDVs (P 
< 0.001; median pairwise difference, 3.3 mL/m2 [95% PIs, −9.4 to 14.1 mL/m2] and iESV: 
P < 0.001; median pairwise difference, 1.4 mL/m2 [95% PIs, −5.2 to 10.1 mL/m2]). In the 
vast majority of cases (98.8% of cases for iEDV and 92.8% of cases for iESV), the difference 
between 2D and 3D TEE indexed volumes did not alter classification into normal, mildly to mod-
erately dilated, or severely dilated volumes, as demonstrated by the 3-zone error grid analysis. 
Acquisition of 3D TEE image and analysis were not feasible in 4 patients (2.5%) for whom a 
quantitative 2D assessment of the LV was also impossible. 3D and 2D quality image was similar 
(P = 0.206). There was no difference in 3D versus 2D acquisition time (P = 0.805; pairwise 
difference = 2 seconds [95% PIs, −20 to 35 seconds]), but 3D analysis required more time 
(P < 0.001; pairwise difference = 117 seconds [95% PIs, 66 to 197 seconds]). Differences 
in repeated 3D versus 2D indexed volumes were not statistically significant, both considering 
interobserver reproducibility (iEDV: P = 0.125; pairwise difference, 0.26 ± 1.76 mL [95% PIs, 
−3.58 to 3.73 mL] and iESV: P = 0.126; pairwise difference, −0.16 ± 1.67 mL [95% PIs, −3.96 
to 3.69 mL]) and intraobserver reproducibility (iEDV: P = 0.975; pairwise difference, −0.02 ± 
1.20 mL [95% PIs, −2.32 to 2.08 mL] and iESV: P = 0.228; pairwise difference, −0.19 ± 1.13 
mL [95% PIs, −2.47 to 2.53 mL]).
CONCLUSIONS: Intraoperative 3D TEE quantification of LV global function, image acquisition 
time, and reproducibility was not statistically different when compared with 2D TEE. It was how-
ever associated with calculation of larger LV volumes and a longer analysis time. Nevertheless, 
the 3-zone error grid analysis of the LV indexed volumes showed that the difference between 
3D and 2D measurements does not affect the LV classification as normal, mildly to moderately 
dilated, or severely dilated.  (Anesth Analg 2014;118:711–20)
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Nevertheless, the reproducibility and accuracy of two-
dimensional (2D) echocardiography may be limited mainly 
because the LV volume measurements are based on geo-
metric assumptions and the LV apex is often foreshortened, 
particularly with TEE.4 ,5 In patients with cardiomyopathies, 
the preconceived assumption of a normal LV shape used in 
calculation could lead to mistakes in quantifying volumes.4,6 
In the past, three-dimensional (3D) echocardiography was 
cumbersome and time consuming, limiting its application 
to research or studies outside the operating room. Recent 
technical improvements have allowed real-time assessments 
with faster and easier use of 3D echocardiography.7 ,8 In this 
setting, several studies using transthoracic echocardiog-
raphy (TTE) have definitely demonstrated the superiority 
of 3D over 2D echocardiography, because semiautomated 
detection of the LV endocardial borders allows rapid, 
accurate, and reproducible measurements of LV volumes, 
showing higher correlation with the reference standards of 
magnetic resonance imaging (MRI) and ventriculography.4,9–11 
3D echocardiography eliminates the need for cognitive 
reconstruction of LV shape by the clinician operator and use 
of geometric assumptions for LV quantification. So far, how-
ever, there is no evidence showing the feasibility and the 
potential advantages of intraoperative 3D LV evaluation in 
comparison to 2D TEE traditional procedures.12–14
The aim of this study was to evaluate the intraoperative 
use of 3D TEE compared with 2D TEE for assessment of LV 
volumes in patients undergoing elective cardiac surgery. 
Specifically, we compared the following: (1) LV volumes and 
ejection fraction (EF) quantified by 3D and 2D TEE; (2) the 
3D and 2D image quality and time requirement for acquisi-
tion and analysis; and (3) the 3D and 2D intra- and interob-
server reproducibility for quantification of LV volumes.
METHODS
Study Population
Between September 2009 and December 2010, we pro-
spectively enrolled 156 consecutive patients who under-
went elective cardiac surgery. Exclusion criteria are listed 
in Table 1. In addition, 4 study patients were excluded for 
inadequate endocardial visualization, and thus, the final 
cohort consisted of 152 patients. All subjects gave written 
informed consent, and the study was approved by the IRB 
of Cardiocentro Hospital in Lugano, Switzerland.
Echocardiography
TEE images of the LV were acquired using an iE33 ultrasound 
system (Philips Medical Systems, Andover, MA) equipped 
with a fully sampled 3D matrix array transducer (X7-2t). 
Both 2D and 3D images were acquired after induction of 
general anesthesia before sternotomy, with the patient in 
supine position, under hemodynamically stable conditions, 
pausing mechanical ventilation in the end-expiratory phase. 
2D and 3D images were acquired within several heartbeats 
by the same experienced operator (AM) who also performed 
all the analyses. The anesthetic was managed in collabora-
tion with a qualified anesthesia nurse according to our rou-
tine institutional practice.
Acquisition time started with the first attempt to find an 
adequate image with the probe at the midesophageal (ME) 
level and ending with the recording of that image. Analysis 
time started with control of all the 2D and 3D images for 
artifacts. The endocardial definition was assessed for each of 
the 17-segment models described in the guidelines through-
out the cardiac cycle. The image quality was then graded 
using a 4-point scale, as shown in Table 2.15 ,16 Analysis time 
ended with the quantification of LV volumes and EF.
The papillary muscles and trabeculae were traced at 
their base and were included in the calculation of the LV 
volume. End diastole was defined as the frame after mitral 
valve closure or the frame in the cardiac cycle in which the 
cardiac dimension is the largest. End systole was identified 
as the frame preceding mitral valve opening or the frame 
in the cardiac cycle in which the cardiac dimension is the 
smallest, according to the current guidelines.17
Two-Dimensional Echocardiography
The 4- and 2-chamber and long-axis views were acquired at 
the ME level over 3 beats. Every effort was made to mini-
mize foreshortening of the LV cavity.
All the images were analyzed with the Philips iE33 
Cardiac Analysis Package (Philips Medical Systems). Two 
basal points at the level of mitral valve annulus and 1 api-
cal point were identified, and the endocardial borders 
were automatically defined and traced; they were manu-
ally traced by the operator both in 4- and 2-chamber views, 
as needed. LV volumes and EF were measured online by 
biplane Simpson’s method according to current guide-
lines.17 2D measurements were obtained over 3 separate 
cardiac cycles and averaged.
Table 1.  Exclusion Criteria
Exclusion criteria No. of patients
Rhythm other than sinus 39
Congenital cardiac disease 13
Hemodynamically unstable condition requiring IV 
catecholamines or IABP before cardiac surgery
50
Extracorporeal membrane oxygenation 12
Esophageal pathologies contraindicating TEE  9
Not elective cardiac surgery 67
IABP = intraaortic balloon pump; TEE = transesophageal echocardiography
Table 2.  Two-Dimensional (2D) and 3D Image Quality Assessment with a 4-Point Scale
Category
No. of patients (%)
3D 2D
Optimal Complete endocardial definition 79 (52) 79 (52)
Good Inadequate visualization of 1 segment 51 (33) 54 (36)
Fair Inadequate visualization of 2 segments, but adequate visualization of adjacent segments 18 (12) 16 (10)
Sufficient Inadequate visualization of 3 segments, but adequate visualization of adjacent segments   4 (3)   3 (2)
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Three-Dimensional Echocardiography
The full-volume 3D echocardiography data set of the LV 
was acquired starting from the ME 4-chamber view over 4 
cardiac cycles and was gated to a stable electrocardiograph 
recording. To optimize the 3D image frame rate, the lateral 
sector width was minimized to include only the mitral and 
aortic valves so that the minimal frame rate was always >20 
Hz (in average 25 Hz).
LV analysis was performed online in the operating room 
using the Philips Q-lab 3D-Advanced quantification soft-
ware (Philips Medical Systems).18 4- and 2-chamber and 
transgastric views were automatically extracted from the 
pyramidal data set, and the quality of endocardial defini-
tion was scrutinized by manually rotating the image on its 
own axis.15
Before initiation of the advanced LV quantification 
process, the ME 4-chamber view was manually adjusted 
by rotating the images on its long axis to remove the LV 
outflow tract. At end diastole and end systole, 5 anatomic 
landmarks were manually identified at the level of the 
mitral valve annulus in the ME 4- and 2-chamber and at 
the apical level to determine the centroid of the LV. Then, 
mitral annular and endocardial boundary identification 
was performed by means of the 3D semiautomatic border 
detection tool. If needed, the end-diastolic and end-systolic 
contour tracing was manually adjusted to provide the high-
est quality sequence. After the sequence analysis, the Q-lab 
software automatically fitted a preconfigured ellipse to the 
endocardial borders for all the frames in the cardiac loop 
by computing a mathematically rendered model. The Q-lab 
software automatically provided parameters of LV global 
function, that is, end-diastolic volume (EDV), end-systolic 
volume (ESV), EF, and stroke volume (SV; Fig. 1).
Statistical Analysis
The a posteriori statistical power was 0.99 for the compari-
son between 3D and 2D EDV. The following quantities were 
specified: 0.05 as significance level (α), 5 mL as clinically rel-
evant difference (δ), and 10 mL as standard deviation of the 
variable in each group (s).
Continuous variables are presented as mean ± SD; LV vol-
umes were indexed to the body surface area and expressed 
as milliliters per square meter. Pairwise differences between 
3D and 2D indexed EDV (iEDV) and ESV (iESV), EF, acqui-
sition time (in seconds) and analyses, and differences in 
repeated 3D and 2D LV indexed volumes were found not 
to follow a normal or a log-normal distribution (all P < 0.01) 
when tested with the Shapiro–Wilk method, and thus were 
analyzed nonparametrically.
The population was categorized according to 
2D-derived EF (≥55%: normal systolic function; 45%–
54%: mildly abnormal; 30%–44%: moderately abnormal; 
<30%: severely abnormal).17 The study population was 
also divided into patients with normal or dilated LV vol-
ume (using an LV iEDV cutoff of 75 mL/m2) based on 
2D-derived values.17
Statistical Methods Used for Comparison Between LV 
Volumes and EF Quantified by 3D and 2D TEE
Means ± SD and median pairwise differences of 3D and 
2D indexed volumes and EF were calculated in the overall 
population and in the above-defined subgroups. The 95% 
prediction intervals (PIs) of the median pairwise differ-
ences were calculated using a binomial method described 
by Clopper and Pearson19 and displayed using a Bland–
Altman plot.20
2D volumes were also plotted against 3D volumes in 
scatter plots. Scatter plots for 3D versus 2D LV iEDV and 
iESV were obtained and were analyzed using 3-zone error 
grid approach, as shown in Figure 2.21 The cutoffs defining 
Figure 1. Left ventricular (LV) assess-
ment by Q-lab software. In the graph, on 
the lower part of the figure, LV volume 
is plotted versus time, with end-diastolic 
volume (EDV) as baseline. ESV = end-
systolic volume; EF = ejection fraction; 
SV = stroke volume.
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the 3 zones (yellow, green, orange) were chosen according 
to the current guidelines: iEDV >96 mL/m2 and/or iESV 
>42 mL/m2 were defined as severely dilated, while iEDV 
≤75 mL/m2 and/or iESV ≤30 mL/m2 were considered nor-
mal.17 The purple line represents our fitted values of 3D 
volumes versus 2D volumes; the green line represents the 
perfect correlation between 3D and 2D measurements. The 
dashed green lines represent a deviation of ±10% of 3D 
LV indexed volumes from the 2D reference. Yellow zone 
was defined by a lowermost section for iEDV ≤75 mL/m2 
or iESV ≤30 mL/m2, an isthmus delimited by the above-
defined dashed green lines, and an uppermost region for 
iEDV >96 mL/m2 or iESV >42 mL/m2. The orange zone 
has an uppermost section for 2D iEDV ≤75 mL/m2 but 3D 
iEDV >96 mL/m2 or 2D iESV ≤30 mL/m2 but 3D iESV >42 
mL/m2 and a lowermost region for 2D iEDV >96 mL/m2 
but 3D iEDV ≤75 mL/m2 or 2D iESV >42 mL/m2 but 3D 
iESV ≤30 mL/m2. Green zone is the area between yellow 
and orange zones.
The equality of matched pairs of 3D and 2D indexed 
volumes and EF in the global population and in the above-
defined subgroups was tested using the Wilcoxon matched-
pairs signed-ranks test (with Bonferroni correction where 
appropriate). The 99% confidence intervals (CIs) median 
pairwise differences between 3D and 2D indexed volumes 
and EF were calculated as well, even though these CI may 
be misleading because their distributions were neither nor-
mal nor log normal.
A nonparametric test for trend across ordered groups 
developed by Cuzic22 was used to test 3D-derived SV across 
the above-defined subgroups of EF.
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Figure 2. Comparison between 3-dimensional (3D) and 2D left ventricular (LV) indexed end-diastolic volume (EDV; A) and indexed end-systolic 
volume (ESV; B) in the study population (n = 152). These values were highly correlated, but 3D volumes were slightly larger than 2D volumes. 
On the left, Bland–Altman plot of the difference in 152 paired LV indexed volumes on the ordinate against the average of the LV indexed vol-
umes on the abscissa. The observed median agreement is displayed as continuous green line, and the 95% prediction intervals are displayed 
as dashed green lines. On the right, scatter plots of paired LV indexed volumes with 3-zone error grid.21 Indexed ventricular volumes obtained 
with the 2D (abscissa) and 3D transesophageal echocardiography (ordinate) were plotted as ordered pairs. The coordinates of the corners of 
the boxes are showed between brackets. Refer to text in the Methods section for more details.
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Statistical Methods Used for Comparing the 3D and  
2D Image Quality and Time Requirement for Acquisition 
and Analysis
Absolute number and percentage of patients were dis-
played in the 4-point scale of image quality, as defined in 
Table 2. Means ± SD of 3D and 2D acquisition time and anal-
ysis time were calculated and displayed in box plot graphs, 
together with median and 25th and 75th percentiles.
The Wilcoxon matched-pairs signed-ranks test was 
used to compare 3D and 2D image quality, as well as the 
3D versus 2D time requirements. The pairwise differences 
between 3D and 2D acquisition and analysis time and their 
corresponding 95% PIs were calculated.19 Manual correction 
of the 3D borders between patients with normal (≥55%) and 
reduced (<55%) EF was expressed as percentage and com-
pared using the Pearson χ2 test.
Statistical Methods Used for Comparing the 3D and 2D 
Intra- and Interobserver Reproducibility for Quantification 
of LV Volumes
Intraobserver reproducibility for 3D and 2D LV indexed 
volumes was tested on a subgroup of 30 patients randomly 
selected. To assess interobserver reproducibility, measure-
ments of the 3D and 2D LV volumes were repeated in all 
patients by a second operator certified for TEE examinations 
who was blinded to the measurements of the first operator. 
Differences in repeated LV indexed volume measurements 
were plotted against their average using a Bland–Altman 
plot to graphically represent the inter- and intrareproduc-
ibility for iEDV and iESV.20,23 The corresponding lines based 
on locally weighted polynomial regression were displayed 
both for 3D and 2D values in the same graph. Differences 
in repeated 3D LV indexed volumes were compared against 
differences in repeated 2D LV indexed volumes using the 
Wilcoxon matched-pairs signed-ranks test. The pairwise dif-
ferences of repeated 3D indexed volumes versus repeated 
2D indexed volumes and their corresponding 95% PIs were 
calculated.19
3D and 2D reproducibility were also expressed with the 
coefficient of variation, defined as the ratio of the SD to the 
mean of the difference between 2 repeated measurements 
per subject. Coefficients of variation for 3D and 2D mea-
surements were compared using the Wilcoxon matched-
pairs signed-ranks test.
Data analyses were performed using STATA software 
(StataCorp, College Station TX) and Excel (Microsoft, 
Redmond, WA). A P value <0.05 was considered statistically 
significant.
RESULTS
LV Volumes and Function
The clinical characteristics of the study population are 
shown in Table 3. Bland–Altman plots of 3D versus 2D iEDV 
(Fig.  2A) and iESV (Fig.  2B) are shown in Figure  2, with 
median pairwise differences and 95% PIs. The observed 
median agreement is above the 0 line, which represents 
perfect matching; since the PIs include the 0 value, by 
repeating the same LV measurements many times in indi-
vidual patients, it would be expected to obtain on average 
3D volumes larger than 2D volumes, but the opposite situ-
ation may also occur. The same results in terms of median, 
pairwise differences and 95% PIs were also obtained in 
the predefined subgroups of patients (i.e., normal, mildly 
abnormal, moderately abnormal, or severely abnormal EF 
and normal or dilated ventricular dimensions), as shown 
in Figure 3.
On the right side of Figure 2, the scatter plots of paired 
LV indexed volumes are displayed together with 3-zone 
error grid analyses.21 The line of the fitted indexed vol-
umes (purple) is above the line of the perfect correlation 
between 3D and 2D (green). Within the yellow zone of the 
3-zone error grid, the discrepancies between 2D and 3D 
measurements have fewer clinical consequences than in 
the other zones. In the large uppermost and lowermost 
regions of yellow zone, even large discrepancies between 
3D and 2D may occur without affecting the LV classifi-
cation as severely dilated or normal, respectively. On the 
contrary, in the isthmus yellow section, 3D and 2D mea-
surements must most closely agree. Therefore, the isth-
mus is the critical area, where even small discrepancies 
between 2D and 3D measurements may lead to a misclas-
sification of the severity of the LV enlargement with pos-
sible clinical consequences. Most of the dots in Figure  2 
(150 of 152 dots for iEDV and 141 of 152 dots for iESV) are 
plotted within this yellow zone. Dots in the orange zone 
would represent severe discrepancies between 2D and 3D 
measurements leading to a relevant misclassification of 
the LV dilation (e.g., LV classified as normal by 3D and 
as severely dilated by 2D); no dots in Figure 2 are plotted 
within the orange zone. The green zone represents some 
discrepancy in LV volumes between 2D and 3D (not as 
severe as in the orange zone). A minority of the dots is 
plotted in this zone (2 of 152 dots for iEDV, 1.3%, and 11 of 
152 dots for iESV, 7.2%).
As shown in Table  4, there was no significant differ-
ence in EF measured by 3D and 2D TEE (median pairwise 
difference, −0.4% [95% PIs, −8.6% to 8.8%]; P  =  0.227). 
Conversely, the LV indexed volumes measured by 3D echo-
cardiography were significantly higher than those mea-
sured by the 2D echocardiography in the entire population. 
Table 3.  Demographics and Type of Surgery
General population (n = 152)
Age, y 68.2 ± 10.7
Female, n (%) 38 (25)
Weight, kg 77.1 ± 14.2
Height, cm 168.6 ± 8.2
BMI, kg/m2 27.1 ± 4.5
BSA, m2 1.89 ± 0.20
Presurgery EF, % 57 ± 12
Type of cardiac surgery, n (%) 174a
 CABG 115 (76)
 Valvular surgery
  Mitral valve 18 (12)
  Aortic valve 32 (21)
 Aortic root surgery 9 (6)
BMI = body mass index; BSA = body surface area; EF = ejection fraction; 
CABG = coronary artery bypass surgery.
aThe majority of the patients underwent CABG or isolated valvular surgery or 
isolated aortic root surgery. Twenty-two patients (14%) underwent a combined 
cardiac surgery (CABG and valvular surgery or aortic valve and aortic root 
surgery), which explains why the total number of surgeries amounts to 152 
+ 22 = 174.
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The same results were also confirmed in the stratification 
done by subgroups: normal, mildly abnormal, moderately 
abnormal, or severely abnormal EF and normal or dilated 
ventricular dimensions.
Three-dimensional–derived SV in the global population 
was 54 ± 20 mL and was progressively larger across the EF 
subgroups according to increase in EF (44 ± 12 mL in the 
severely abnormal systolic function subgroup; 51 ± 16 mL 
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Figure 3. Bland–Altman plot of the 3-dimensional (3D) left ventricular (LV) indexed end-diastolic volume (EDV) against the 2D LV indexed end-
systolic volume (ESV) in the stratification done by subgroups: normal, mildly abnormal, moderately abnormal, or severely abnormal ejection 
fraction (A) and normal or dilated ventricular dimensions (B). The observed median agreement is displayed as continuous green line, and the 
95% prediction intervals are displayed as dashed green lines.
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in moderately abnormal systolic function; 52 ± 18 mL in 
mildly abnormal systolic function; 57 ± 21 mL in the normal 
systolic function subgroups; P = 0.024).
Image Quality and Time Requirement
As shown in Table 2, the quality of 3D TEE images was opti-
mal in more than half of the study population and resulted 
in similar 2D image quality (P = 0.206). It was necessary to 
repeat the 2D acquisition in 23 patients (for a total of 32 2D 
images) and the 3D acquisition in 19 patients to improve the 
image quality.
The time required for 2D and 3D imaging is compared 
in Figure 4. There was no difference in the time required for 
acquisition of 3D and 2D images (P = 0.805; pairwise differ-
ence = 2 seconds [95% PIs, −20 to 35 seconds]), but analy-
sis of 3D images required significantly more time than 2D 
images (P < 0.001; pairwise difference = 117 seconds [95% 
PIs, 66 to 197 seconds]). A manual correction of the 3D auto-
mated border detection was required in 59% of the 3D TEE 
images in 73% of patients with abnormal EF and in 52% of 
those with normal EF (P = 0.009), especially at the level of 
the lateral apex (in 57 patients, 37%) and inferior apex (in 45 
patients, 29%).
Reproducibility
Figure 5 presents the inter- and intrareproducibility anal-
yses for iEDV and iESV. In each graph, the distribution 
of the 3D and 2D measurements and the corresponding 
lines based on locally weighted polynomial regression are 
within the same range of values. Differences in repeated 
3D versus 2D indexed volumes were not statistically sig-
nificant, both considering interobserver reproducibility 
(iEDV: P = 0.125; pairwise difference, 0.26 ± 1.76 mL [95% 
PIs, −3.58 to 3.73 mL] and iESV: P  =  0.126; pairwise dif-
ference, −0.16 ± 1.67 mL [95% PIs, −3.96 to 3.69 mL]) and 
intraobserver reproducibility (iEDV: P  =  0.975; pairwise 
difference, −0.02 ± 1.20 mL [95% PIs, −2.32 to 2.08 mL] and 
iESV: P = 0.228; pairwise difference, −0.19 ± 1.13 mL [95% 
PIs, −2.47 to 2.53 mL]).
Considering interobserver reproducibility, we found 
coefficients of variation of 3.2% for 3D iEDV versus 2.9% 
for 2D iEDV (P = 0.195) and 7.9% for 3D iESV versus 8.9% 
for 2D iESV (P = 0.165). Considering intraobserver repro-
ducibility, the calculated coefficients of variation were 2.0% 
for 3D iEDV compared with 2.2% for 2D iEDV (P = 0.781) 
and 4.1% for 3D iESV compared with 4.7% for 2D iESV 
(P = 0.280).
Table 4.  Three-Dimensional (3D) and 2D Indexed Volumes and Function in the Entire Study Population 
(n = 152) and in Subgroups of Patients
3D TEE 2D TEE P value Median pairwise difference (99% CI)
EF, % 55 ± 14 55 ± 14 0.227 −0.4 (−1.2 to 0.3)
iEDV, mL/m2 54 ± 21 51 ± 21 <0.001 3.3 (2.5 to 4.2)
iESV, mL/m2 26 ± 18 24 ± 17 <0.001 1.4 (1.0 to 2.0)
3D and 2D iEDV in mL/m2 in subgroups of patients (the percentage of the entire population represented in each subgroup is reported in brackets), 
according to the following:
 Systolic function
  Normal (62%) 47 ± 16 43 ± 15 <0.001 3.2 (2.3 to 4.4)
  Mildly abnormal (16%) 53 ± 14 51 ± 12 0.794 3.6 (−3.8 to 5.8)
  Moderately abnormal (14%) 71 ± 23 67 ± 23 0.001 3.3 (1.6 to 6.2)
  Severely abnormal (8%) 89 ± 23 85 ± 24 0.023 3.9 (0.7 to 6.9)
 Ventricular volume
  Normal (86%) 48 ± 12 45 ± 12 <0.001 3.5 (2.4 to 4.2)
  Dilated (14%) 101 ± 19 96 ± 17 0.002 3.2 (1.2 to 5.6)
CI = confidence interval; EF = ejection fraction; iEDV = indexed end-diastolic volume; iESV = indexed end-systolic volume; TEE = transesophageal echocardiography.
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Figure 4. The box plot graphs show the acquisition time (A) and the 
analysis time (B) of 2-dimensional (2D) midesophageal (ME) 4- and 
2-chamber views (blue boxes) and 3D left ventricular full volume (red 
boxes). The boxes are determined by the 25th = Q1 and 75th = Q3 
percentiles, and the line in the middle of the box is the median; the 
lower whisker indicates Q1 − 1.5 × (Q3 − Q1), and the upper whisker 
indicates Q3 + 1.5 × (Q3 − Q1). The numbers showed represent the 
mean ± SD.
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DISCUSSION
In the present study, we compared intraoperative 3D with 
2D TEE for the evaluation of LV volumes and EF. Previous 
TTE studies have focused on 3D LV assessment, suggesting 
that 3D is more precise and accurate for LV volume quan-
tification than 2D and offers reproducible information.4,9 
However, less information is available regarding 3D TEE in 
the perioperative setting. In this study, we noted larger 3D 
LV volumes than 2D LV volumes and that 3D TEE needed 
longer analysis time with respect to 2D. Our results showed 
no difference in terms of LV EF, image quality, and repro-
ducibility between 3D and 2D TEE.
LV Volumes and Function
Our results showed a difference between LV indexed vol-
umes measured by 3D and 2D TEE as 3D volumes were 
larger than 2D volumes. This difference appeared statis-
tically significant when tested by the Wilcoxon matched-
pairs signed-ranks test and expressed as CIs of median 
pairwise differences. However, the median pairwise dif-
ference between 3D versus 2D volumes is on the order of 
a few milliliters (i.e., 3.3 mL/m2 for iEDV and 1.4 mL/m2 
for iESV) and the PIs included the 0 value, indicating that 
the clinical relevance of these differences is small. This con-
sideration is also supported by 3-zone error grid analysis 
of the LV indexed volumes showing that the difference 
between 3D and 2D measurements does not affect the LV 
classification as normal, mildly to moderately dilated, or 
severely dilated.
With respect to LV function, there were no differences 
between 3D and 2D EF, suggesting that the evaluation of 
LV global function by 3D TEE is comparable with 2D TEE. 
As EF is calculated from a simple algebraic equation ([EDV 
− ESV]/EDV), a systematic upshift of 3D LV volumes ver-
sus 2D LV volumes leads to a cancelation in the differences 
between 3D and 2D EF.
The 3D echocardiography also allowed us to assess the 
LV function by means of 3D-derived SV. Quantification of 
LV cardiac output by 3D TTE echocardiography has been 
validated against thermodilution24 or MRI.11 A good cor-
relation between 3D-derived SV and thermodilution was 
reported by Culp et al.25 However, there were significant 
bias and wide limits of agreement, limiting the overall accu-
racy of the 3D TEE measurements. In our study, we found 
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Figure 5. Bland–Altman plot for interobserver (A) and intraobserver reproducibility (B) of indexed end-diastolic volume (EDV; left side) and 
indexed end-systolic volume (ESV; right side). Dots in blue represent 3-dimensional (3D) measurements, and dots in red represent 2D mea-
surements. The corresponding lines are based on locally weighted polynomial regression.
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that 3D-derived SV progressively decreased according to 
worsening in 2D-derived EF.
Image Quality and Time Requirements
The success rate for 3D image acquisition and analysis 
was equal to that of 2D echocardiography. The visualiza-
tion of LV endocardium by 3D TEE was optimal to good 
in 85% of our study population, in line with encouraging 
data reported in the literature.26 In this study, 3D image 
quality was similar to 2D, the latter also being similar to 
previous data in the literature on endocardial visualiza-
tion with 2D TEE.27
Although acquisition times were similar in 3D and 2D, 
3D analysis to obtain LV volumes and EF required more 
time than 2D, and this could be a disadvantage of the use of 
3D in the operating room. However, the 5-minute average 
needed to analyze LV with 3D was still compatible with the 
pace of our operating room activity. Moreover, 3D provides 
a complete characterization of LV including information on 
regional function,15 ,28 which would need additional time 
with 2D TEE. Although not the topic of the present study, 
evaluation of LV regional function is of potential impor-
tance during cardiac surgery to facilitate detection of myo-
cardial ischemia.
Reproducibility
Our data on intra- and interobserver reproducibility for 3D 
indexed volumes were satisfactory, and 3D reproducibility 
was similar to 2D reproducibility29 but failed to be clearly 
superior in contrast to TTE studies.4,8,10 ,11 These discordant 
results may be partly explained by the fact that our mea-
surements were performed on TEE, unlike the previous TTE 
studies.
Limitations
Some limitations of this study should be noted. First, 3D 
LV measurements in our patients were compared only 
with 2D values, both acquired with TEE and, as is well 
known, transesophageal imaging techniques involve dif-
ficulties in the visualization of the apex and lateral heart 
wall. A comparison with reference techniques such as 
MRI or 3D TTE would be necessary for final validation of 
3D TEE measures. For this purpose, studies of 3D TEE in 
the echo laboratory appear to be more appropriate, being 
performed in hemodynamic conditions similar to the ref-
erence technique. Intraoperatively, we could not perform 
3D TTE in the same hemodynamic conditions as TEE for 
technical reasons (surgical preparation was underway and 
a cardiologist trained in 3D TTE acquisition was not avail-
able). The validation of 3D TEE volumes measured intra-
operatively against pre- or postoperative MRI would be 
logistically challenging. Second, no comparison between 
LV assessed by Philips Q-lab 3D-Advanced software and 
different 3D software was done, and 3D-derived SV was not 
compared with thermodilution. Third, this study was per-
formed in patients undergoing elective cardiac surgery hav-
ing hemodynamically stable conditions and sinus rhythm. 
Finally, a single operator acquired and analyzed both 2D 
and 3D images. Therefore, bias cannot be excluded in per-
forming 2D and 3D measurements and analyses. However, 
all measurements were repeated by a second experienced 
operator and interobserver differences were small and not 
statistically significant.
In conclusion, intraoperative 3D TEE of LV demon-
strated no differences compared with 2D TEE in terms 
of LV EF, image quality, and reproducibility. The 3D 
required more time compared with 2D TEE, and ventricu-
lar volumes measured by 3D TEE were larger than those 
obtained from 2D TEE. However, the difference between 
3D and 2D volumes was on the order of a few milliliters 
and did not affect the classification of LV as normal, mildly 
to moderately dilated, or severely dilated using the 3-zone 
grid analysis, thus limiting the clinical relevance of these 
differences. E
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